Description
KLOW is a research-grade four-component peptide blend at 80mg total, combining KPV, GHK-Cu (Copper Tripeptide-1), BPC-157 (Body Protection Compound 157), and TB-500 (Thymosin Beta-4). KLOW has been used in research investigating combined peptide activity across melanocortin, copper-tripeptide, gastric juice-derived, and actin-binding research peptide pathways simultaneously.
This multi-component research blend offers a useful tool for cellular research investigating overlapping peptide pathways in a single research-grade preparation.
Blend composition
- BPC-157 — 10mg
- TB-500 (Thymosin Beta-4) — 10mg
- GHK-Cu (Copper Tripeptide-1) — 50mg
- KPV — 10mg
- Total: 80mg
Research areas studied
- Multi-component research peptide pharmacology
- Combined peptide pathway research
- Comparative blend studies vs. individual components
Quality assurance
- HPLC verified at 99%+ purity
- Certificate of Analysis (COA) available upon request
- Lyophilized in a research-grade facility under controlled conditions
For research purposes only. Not for human consumption, diagnostic, or therapeutic use.